- Investing.com
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients’ mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare services clients, including single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies, as well as government entities and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
Digital Health Pionee | Explore Phreesia's multifaceted platform revolutionizing patient engagement, administrative efficiency, and pharmaceutical marketing in the evolving healthcare IT landscape |
Financial Momentum | Delve into Phreesia's impressive revenue growth, improving profitability metrics, and transition to positive adjusted EBITDA and free cash flow generation |
Strategic Expansion | Learn how Phreesia's partnerships with large specialty provider networks and diverse revenue streams are driving scalability and market penetration |
Market Outlook | Analyst price targets range from $34 to $35, reflecting confidence in Phreesia's growth potential and its positioning as a "growth-at-a-reasonable-price" opportunity |
Metrics to compare | PHR | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipPHRPeersSector | |
---|---|---|---|---|
P/E Ratio | −58.7x | −0.9x | −0.7x | |
PEG Ratio | −0.76 | −0.01 | 0.00 | |
Price/Book | 4.7x | 0.5x | 2.6x | |
Price / LTM Sales | 3.1x | 1.4x | 3.4x | |
Upside (Analyst Target) | 46.1% | 51.0% | 36.2% | |
Fair Value Upside | Unlock | 9.5% | 4.1% | Unlock |